|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
Nutra Pharma Corp (Name of Issuer) |
Series B Preferred Shares (Title of Class of Securities) |
(CUSIP Number) |
Elizabeth Deitsch 7915 NW 111th Way, Parkland, FL, 33076 954-295-7232 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
08/21/2026 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Pure Raw Supplies, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
FLORIDA
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
12,000,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
100 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Series B Preferred Shares |
| (b) | Name of Issuer:
Nutra Pharma Corp |
| (c) | Address of Issuer's Principal Executive Offices:
6400 Park of Commerce Blvd, Suite 1B, Boca Raton,
FLORIDA
, 33487. |
| Item 2. | Identity and Background |
| (a) | Pure Raw Supplies, LLC, a Florida limited liability company |
| (b) | 7915 NW 111th Way, Parkland, FL 33076 |
| (c) | The principal business of the Reporting person is pharmaceutical consulting. |
| (d) | During the past five years, the Reporting Person has not (i) been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which it became or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (e) | During the past five years, the Reporting Person has not (i) been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which it became or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | FL |
| Item 3. | Source and Amount of Funds or Other Consideration |
The Reporting Person acquired beneficial ownership of the Shares through a bona fide gift from Rik Deitsch on August 21, 2026. No funds were borrowed or otherwise used by the Reporting Person to acquire the Shares, and no consideration was paid by the Reporting Person in connection with such acquisition | |
| Item 4. | Purpose of Transaction |
The Reporting Person acquired the Shares pursuant to a bona fide gift and not as part of any purchase transaction. The Reporting Person holds the Shares for investment purposes. The Reporting Person does not presently have any plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of Schedule 13D. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | 12,000,000; 100% |
| (b) | 12,000,000 |
| (c) | None other than the transactions described in Item 4 of this Schedule 13D. |
| (d) | To the knowledge of the Reporting Person, no person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported herein, |
| (e) | N/A |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
None. | |
| Item 7. | Material to be Filed as Exhibits. |
None. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|